From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes that the company has recently crossed from being a candidate to being an approved/specified/listed/qualified/etc. choice inside buyers' systems, such that future business can arrive without discrete selling events, and that this status is new enough that most volume is ahead. Scan the transcript for such descriptions. Management discusses design wins, new products, partnerships, but we need to see if they describe being placed into a buyer's routine purchasing pathway (e.g., approved vendor list, specification, etc.) and that it's recent and will unlock future volume. Key points: - "we recently secured a design win from a Tier 1 cable operator for its next generation Wi-Fi 7 CPE." That's a design win, but does that mean they are now specified? Design win typically means they are chosen for a specific product, but it's still a discrete selling event for that product. However, being designed into a product means that for that product's lifecycle, they are the supplier, so it's a form of being specified. But is it described as a new status that will bring recurring orders without re-arguing? Possibly, but the transcript doesn't explicitly say that they are now on an approved list or that future orders will come automatically. It says "secured a design win" and "expect to begin shipment in Q1." That's a standard customer win. - "we recently secured a large design win with a Tier 1 mobile network operator, or MNO, for the antenna design in their indoor FWA router, for which we expect to begin shipment in Q1." Similar. - "we signed a new system integrator in the public safety and municipality market that we believe will contribute significantly to our automotive sales next year." That's a distribution partner, not necessarily a gateway. - "we expect to have added five new distribution partners and a major system integration partner" - distribution partners are just channels, not necessarily approved status. - "we have been in the market for over three years and have built a strong pipeline of deals" for asset trackers, but that's not about being placed into a system. - The product initiatives: Lantern FWA, Lighthouse Smart Repeater, vehicle networking. They are targeting ship dates, but not yet placed into buyer systems. - "we have secured early purchase orders for the Lantern FWA products" - that's just orders.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.